Peer-reviewedCC BYCancers
Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
- 1Hospital Universitario San Pedro, 26006 Logroño, Spain
- 2Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen Del Rocío (HUVR), Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, 41013 Sevilla, Spain
Related
- Plant-Derived Bioactive Compounds, Cancer Stemness and Cellular Senescence: A Narrative Review of Preclinical Evidence and Translational Relevance to Cancer Recurrence and Drug Resistance
- Bidirectional cellular senescence crosstalk in MASLD: mechanisms, disease progression, and treatment strategies
- Metal-based epigenetic therapeutics in cancer: Mechanisms, targets, and opportunities for overcoming drug resistance
- Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective
- Autophagy in Pituitary Neuroendocrine Tumors (PitNETs): Molecular Mechanisms, Secretory Homeostasis, Therapeutic Resistance, and Translational Perspectives
BibTeX
@article{blanco2026therapyinduced,
title = {{Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities}},
author = {Jose-Ramon Blanco and Amancio Carnero},
journal = {Cancers},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664522},
note = {CC BY},
}
RIS
TY - JOUR
TI - Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
AU - Jose-Ramon Blanco
AU - Amancio Carnero
PY - 2026
DA - 2026/09/23
JO - Cancers
UR - https://europepmc.org/article/PMC/PMC13664522
SN - 2072-6694
ER -